ACLX
Price
$75.63
Change
+$0.42 (+0.56%)
Updated
Dec 20, 04:59 PM (EDT)
88 days until earnings call
CRSP
Price
$40.76
Change
+$0.38 (+0.94%)
Updated
Dec 20, 04:59 PM (EDT)
58 days until earnings call
Ad is loading...

ACLX vs CRSP

Header iconACLX vs CRSP Comparison
Open Charts ACLX vs CRSPBanner chart's image
Arcellx
Price$75.63
Change+$0.42 (+0.56%)
Volume$4.84K
CapitalizationN/A
CRISPR Therapeutics AG
Price$40.76
Change+$0.38 (+0.94%)
Volume$37.11K
CapitalizationN/A
ACLX vs CRSP Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. CRSP commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and CRSP is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ACLX: $75.54 vs. CRSP: $40.72)
Brand notoriety: ACLX and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 223% vs. CRSP: 188%
Market capitalization -- ACLX: $4.09B vs. CRSP: $3.48B
ACLX [@Biotechnology] is valued at $4.09B. CRSP’s [@Biotechnology] market capitalization is $3.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 6 bearish.
  • CRSP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -9.86% price change this week, while CRSP (@Biotechnology) price change was -6.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

CRSP is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.09B) has a higher market cap than CRSP($3.48B). ACLX YTD gains are higher at: 36.108 vs. CRSP (-34.952). ACLX has higher annual earnings (EBITDA): -33.12M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. ACLX (574M). ACLX has less debt than CRSP: ACLX (65.3M) vs CRSP (228M). CRSP has higher revenues than ACLX: CRSP (200M) vs ACLX (156M).
ACLXCRSPACLX / CRSP
Capitalization4.09B3.48B118%
EBITDA-33.12M-313.08M11%
Gain YTD36.108-34.952-103%
P/E RatioN/AN/A-
Revenue156M200M78%
Total Cash574M1.94B30%
Total Debt65.3M228M29%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXCRSP
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CDL65.140.80
+1.24%
VictoryShares US LgCp Hi Div Vol Wtd ETF
LVHI29.990.01
+0.03%
Franklin Intl Low Volatility Hi Div ETF
AUDJPY98.23N/A
N/A
Australian Dollar - Japan Yen
CNYHKD1.06N/A
N/A
China Yuan - Hong Kong Dollar
GBPNZD2.22N/A
N/A
United Kingdom Pound - New Zealand Dollar

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.44%
DNLI - ACLX
49%
Loosely correlated
-0.19%
BEAM - ACLX
49%
Loosely correlated
+8.04%
RCKT - ACLX
48%
Loosely correlated
+1.85%
CRSP - ACLX
47%
Loosely correlated
+0.83%
RCUS - ACLX
47%
Loosely correlated
+0.26%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+0.83%
BEAM - CRSP
73%
Closely correlated
+8.04%
PRME - CRSP
62%
Loosely correlated
+3.94%
NTLA - CRSP
62%
Loosely correlated
+0.83%
RXRX - CRSP
60%
Loosely correlated
-0.99%
EDIT - CRSP
59%
Loosely correlated
-2.24%
More